More on Newborn Screening for Lysosomal Diseases

Screening is Critical for Improved Outcomes!

Following-up on our previous post about the recent achievement in newborn screening for two lysosomal diseases in the state of Washington, the Association of Public Health Laboratories (“APHL”) has an excellent brief article by Michelle Forman, APHL’s senior specialist for media, posted on their blog on March 1, 2016, which provides both facts and insights about newborn screening for lysosomal diseases. Have you been wondering why getting the lysosomal diseases included in all 50 states’ newborn screening programs is taking so long and is requiring so much effort? Read Michelle’s cogent post, and you’ll know exactly why!